?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
518 Unternehmen gefunden • Seite 8 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Tongrentang Co Ltd | 50.6 | Arzneimittel (Pharmazeutisch) | China | 4.8 Mrd. USD | 33.08 | - | 2.02 | 2.36 | ▲ 6.11% | ▲ 2.89% | 2.14% | ▲ 5.06% | 2 Jahre | 6.89% | ▼ -0.41% | 12.10% | ▼ -1.03% | 13.53% | ▼ -3.01% | 6 / 9 | 8,27 | 21-fach | 32 / 100 | −6,6 / 100 | −3,80 | |
| Yuhan Corp. | 50.6 | Arzneimittel (Pharmazeutisch) | Südkorea | 4.1 Mrd. USD | 24.65 | - | 2.56 | 2.45 | ▲ 6.18% | ▲ 0.14% | 0.76% | - | - | 8.88% | ▲ 0.37% | 4.77% | ▲ 0.44% | -1.76% | ▼ -1.55% | 7 / 9 | 7,19 | 13-fach | 23 / 100 | 2,8 / 100 | −2,26 | |
![]() | ANI Pharmaceuticals Inc | 50.6 | Arzneimittel (Pharmazeutisch) | USA | 1.6 Mrd. USD | 15.24 | 11.79 | 1.65 | 2.70 | ▲ 33.48% | - | - | - | - | 8.87% | ▲ 6.93% | 9.20% | ▲ 6.65% | 17.08% | ▲ 7.57% | 6 / 9 | 3,28 | 2-fach | 31 / 100 | −7,4 / 100 | −2,62 |
![]() | CSPC Pharmaceutical Group Ltd | 50.5 | Arzneimittel (Pharmazeutisch) | China | 12.7 Mrd. USD | 10.26 | 42.58 | 2.27 | 2.26 | ▲ 1.44% | ▼ -5.53% | 3.33% | ▲ 10.76% | - | 15.32% | ▼ -1.50% | 15.27% | ▼ -1.78% | 15.74% | ▼ -0.01% | 4 / 9 | 7,07 | > 50-fach | 37 / 100 | −4,4 / 100 | −2,52 |
| Ono Pharmaceutical Co Ltd | 50.4 | Arzneimittel (Pharmazeutisch) | Japan | 7.0 Mrd. USD | 13.98 | 8.21 | 2.11 | 1.26 | ▲ 12.07% | ▼ -0.39% | 3.36% | ▼ -63.55% | - | 13.53% | ▼ -3.24% | 20.03% | ▼ -3.65% | 25.36% | ▲ 0.61% | 7 / 9 | 8,47 | 36-fach | 36 / 100 | −6,4 / 100 | −2,81 | |
![]() | Ipsen SA | 50.4 | Arzneimittel (Pharmazeutisch) | Frankreich | 15.0 Mrd. USD | 15.32 | 10.58 | 3.21 | 2.75 | ▲ 6.47% | ▼ -4.10% | 1.02% | ▲ 9.86% | 1 Jahre | 12.09% | ▼ -3.37% | 20.30% | ▼ -3.99% | 28.10% | ▲ 0.21% | 8 / 9 | 3,90 | 10-fach | 37 / 100 | −10,0 / 100 | −2,57 |
| Zhejiang Medicine Co Ltd | 50.2 | Arzneimittel (Pharmazeutisch) | China | 1.8 Mrd. USD | 15.78 | 16.69 | 1.34 | 1.05 | ▲ 3.92% | ▲ 4.01% | 2.27% | ▲ 16.27% | - | 9.83% | ▲ 0.25% | 12.15% | ▲ 0.53% | 16.21% | ▲ 3.94% | 6 / 9 | 8,03 | 30-fach | 22 / 100 | −7,3 / 100 | −3,19 | |
![]() | Fennec Pharmaceuticals Inc | 50.0 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 6.49 | 9.06 | ▲ 204.69% | ▼ -11.66% | - | - | - | -21.82% | ▲ 2190.74% | -14.22% | ▲ 2172.04% | -27.94% | ▲ 1790.91% | 1 / 9 | −5,10 | −1,7-fach | 58 / 100 | 3,9 / 100 | −0,84 |
![]() | Lineage Cell Therapeutics Inc | 50.0 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 19.52 | 4.19 | ▲ 79.88% | ▲ 25.20% | - | - | - | -436.47% | ▲ 131.82% | -149.62% | ▲ 215.40% | -133.56% | ▲ 70.71% | 4 / 9 | −14,00 | - | 12 / 100 | −39,2 / 100 | −3,22 |
![]() | Liquidia Technologies Inc | 50.0 | Arzneimittel (Pharmazeutisch) | USA | 6.0 Mrd. USD | 43.10 | 98.72 | 13.25 | 30.62 | ▲ 192.49% | ▲ 2.89% | - | - | - | -43.53% | ▼ -22.33% | -32.45% | ▼ -16.23% | -25.28% | ▼ -3.90% | 5 / 9 | −5,88 | −5,5-fach | 44 / 100 | −10,1 / 100 | 6,03 |
| High Tide Inc | 49.8 | Arzneimittel (Pharmazeutisch) | Kanada | 0.2 Mrd. USD | - | 20.45 | 0.46 | 3.48 | ▲ 48.14% | ▲ 51.52% | - | - | - | -8.54% | ▲ 4.01% | -2.43% | ▲ 3.70% | 2.23% | ▲ 2.56% | 3 / 9 | −2,21 | −1,8-fach | 46 / 100 | −22,4 / 100 | −3,41 | |
| PKU HealthCare Corp Ltd | 49.6 | Arzneimittel (Pharmazeutisch) | China | 0.5 Mrd. USD | 83.65 | 40.78 | 3.29 | 2.11 | ▼ -5.60% | ▲ 16.17% | 4.25% | - | - | 5.59% | ▲ 1.13% | 10.68% | ▲ 2.07% | 22.84% | ▲ 4.77% | 7 / 9 | 9,52 | 26-fach | 21 / 100 | −15,3 / 100 | −3,71 | |
![]() | Akebia Ther | 49.5 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | 6.56 | 1.20 | 10.54 | ▼ -4.37% | ▼ -56.67% | - | - | - | -2.26% | ▲ 21.31% | 9.95% | ▲ 26.45% | 28.66% | ▲ 29.39% | 6 / 9 | −13,73 | −1,6-fach | 52 / 100 | −19,5 / 100 | −2,81 |
| Galderma Group N | 49.3 | Arzneimittel (Pharmazeutisch) | Schweiz | 44.2 Mrd. USD | 51.61 | 42.79 | 7.56 | 5.37 | - | - | 0.23% | - | - | 12.25% | ▲ 4.13% | 16.71% | ▲ 1.96% | 19.67% | ▲ 3.98% | 7 / 9 | 3,77 | 2-fach | 27 / 100 | −4,1 / 100 | −2,58 | |
![]() | Madrigal Pharmaceuticals Inc | 49.2 | Arzneimittel (Biotechnologie) | USA | 12.3 Mrd. USD | - | - | 9.62 | 23.58 | ▲ 130.27% | ▲ 50.40% | - | - | - | -30.08% | ▲ 4364.50% | -31.31% | ▲ 4241.55% | -19.83% | ▲ 3814.23% | 3 / 9 | −0,99 | −19,9-fach | 72 / 100 | −7,8 / 100 | 0,59 |
| Guobang Pharma Ltd | 48.9 | Arzneimittel (Pharmazeutisch) | China | 1.8 Mrd. USD | 17.37 | - | 2.00 | 1.46 | ▲ 7.40% | ▲ 0.27% | 2.73% | - | - | 13.65% | ▼ -0.69% | 16.00% | ▼ -0.71% | 4.68% | ▲ 3.82% | 6 / 9 | 8,02 | 31-fach | 14 / 100 | 2,4 / 100 | −2,56 | |
![]() | Seegene Inc | 48.7 | Arzneimittel (Biotechnologie) | Südkorea | 1.0 Mrd. USD | 17.93 | 14.76 | 2.82 | 1.38 | ▼ -15.87% | ▼ -37.40% | 3.80% | ▼ -5.59% | - | 10.18% | ▼ -8.42% | 7.29% | ▼ -11.64% | 22.96% | ▼ -1.37% | 9 / 9 | 11,38 | 4-fach | 25 / 100 | −8,2 / 100 | −2,76 |
![]() | Hikma Pharmaceuticals PLC | 48.7 | Arzneimittel (Pharmazeutisch) | Vereinigtes Königreich - UK | 4.3 Mrd. USD | 11.10 | 28.91 | 1.26 | 1.69 | ▲ 7.42% | ▼ -0.97% | 4.30% | ▲ 17.48% | - | 12.26% | ▼ -0.45% | 17.32% | ▼ -1.89% | 4.94% | ▼ -2.15% | 6 / 9 | 4,50 | 6-fach | 25 / 100 | 0,8 / 100 | −2,17 |
| RemeGen Co. Ltd. A | 48.6 | Arzneimittel (Biotechnologie) | China | 9.6 Mrd. USD | 91.36 | - | 19.91 | 27.90 | - | - | - | - | - | 21.79% | ▲ 4.86% | 22.19% | ▲ 6.56% | -4.42% | ▲ 21.87% | 5 / 9 | −3,55 | −12,7-fach | 25 / 100 | −5,3 / 100 | −2,84 | |
| Zhejiang Garden Bio-chemical High-tech Co Ltd | 48.5 | Arzneimittel (Pharmazeutisch) | China | 1.2 Mrd. USD | 28.60 | - | 6.08 | 2.20 | ▲ 13.41% | ▲ 2.98% | 0.78% | ▲ 1.87% | - | 24.64% | ▼ -3.95% | 30.95% | ▼ -4.53% | 9.11% | ▲ 5.37% | 6 / 9 | 5,11 | 10-fach | 12 / 100 | −2,9 / 100 | −2,17 | |
| Nanjing King-friend Biochemical Pharmaceutical Co Ltd | 48.5 | Arzneimittel (Pharmazeutisch) | China | 1.8 Mrd. USD | 24.86 | 79.18 | 3.05 | 1.73 | ▲ 6.48% | ▼ -6.32% | 1.35% | - | - | 14.57% | ▼ -3.66% | 14.57% | ▼ -4.12% | 15.60% | ▲ 4.00% | 6 / 9 | 6,61 | 8-fach | 15 / 100 | −5,8 / 100 | −2,95 | |
![]() | Phibro Animal Health Corporation | 48.5 | Arzneimittel (Pharmazeutisch) | USA | 1.4 Mrd. USD | 14.50 | 146.59 | 0.95 | 3.75 | ▲ 12.74% | ▲ 12.89% | 1.35% | - | - | 6.57% | ▲ 0.31% | 13.07% | ▲ 1.06% | 0.65% | ▲ 0.96% | 6 / 9 | 4,66 | 3-fach | 34 / 100 | 2,1 / 100 | −2,31 |
![]() | Hangzhou Tigermed Consulting Co Ltd | 48.3 | Arzneimittel (Biotechnologie) | China | 4.5 Mrd. USD | 326.68 | 25.36 | 4.19 | 1.57 | ▲ 16.44% | ▼ -12.69% | 0.35% | ▼ -16.75% | - | 12.99% | ▼ -10.65% | 14.77% | ▼ -7.05% | 13.23% | ▼ -1.56% | 7 / 9 | 7,74 | 13-fach | 7 / 100 | −0,9 / 100 | −2,32 |
![]() | Harrow Health Inc | 48.3 | Arzneimittel (Pharmazeutisch) | USA | 1.3 Mrd. USD | - | 243.98 | 4.69 | 85.04 | ▲ 40.99% | ▲ 8.89% | - | - | - | -1.89% | ▲ 5.31% | 14.18% | ▲ 2.62% | 15.70% | ▲ 7.24% | 6 / 9 | 1,15 | 0-fach | 51 / 100 | −12,3 / 100 | −3,04 |
![]() | Novavax Inc | 48.2 | Arzneimittel (Biotechnologie) | USA | 1.6 Mrd. USD | - | - | 3.75 | -8.15 | ▲ 18.76% | - | - | - | - | 39.19% | ▲ 39.63% | 50.14% | ▲ 39.84% | -22.27% | ▼ -7.37% | 6 / 9 | −7,22 | −3,8-fach | 89 / 100 | 58,2 / 100 | 0,66 |